IM2 regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IM2 regimen, covering 2023-06-28 to 2023-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia [Phase 2]